Chemoinformaics analysis of 2,3,1-Benzodiazaborine, 1,2-dihydro-1-methyl-
| Molecular Weight | 143.986 | nRot | 0 |
| Heavy Atom Molecular Weight | 134.914 | nRig | 11 |
| Exact Molecular Weight | 144.086 | nRing | 2 |
| Solubility: LogS | -1.749 | nHRing | 1 |
| Solubility: LogP | 0.708 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.5911 |
| nHD | 1 | BPOL | 13.6789 |
| QED | 0.525 |
| Synth | 3.614 |
| Natural Product Likeliness | -0.133 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.96 |
| HIA | 0.234 |
| CACO-2 | -4.859 |
| MDCK | 0.0000236 |
| BBB | 0.917 |
| PPB | 0.885652 |
| VDSS | 1.618 |
| FU | 0.143822 |
| CYP1A2-inh | 0.913 |
| CYP1A2-sub | 0.864 |
| CYP2c19-inh | 0.104 |
| CYP2c19-sub | 0.484 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.813 |
| CYP3a4-inh | 0.044 |
| CYP3a4-sub | 0.206 |
| CL | 2.697 |
| T12 | 0.924 |
| hERG | 0.002 |
| Ames | 0.979 |
| ROA | 0.212 |
| SkinSen | 0.355 |
| Carcinogencity | 0.983 |
| EI | 0.989 |
| Respiratory | 0.613 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.854627 |